A prospective, randomized, double-blind, placebo-controlled trial of multimodal intraoperative analgesia for laparoscopic excision of endometriosis.

A prospective, randomized, double-blind, placebo-controlled trial of the efficacy of multimodal intraoperative analgesia on post-operative pain levels and analgesia requirements on laparoscopic excision of endometriosis.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000217606

Enrollment

166

Registered

2005-08-26

Start date

2004-05-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Multimodal analgesia (Diclofenac sodium 100mg suppository PR, 0.75% Ropivacaine)

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

Consent to laparoscopic excision of suspected endometriosis. Capable to complete questions relating to pain, nausea and vomiting.

Exclusion criteria

Failure to give informed consent to participate in trialAllergy or hypersensitivity to amide type local anaestheticsContraindications to use of PR VoltarenPotential for drug interactions with the use of PR VoltarenKnown history of hypersensitivity to paracetamolContraindications to use of morphineSurgical procedure other than laparoscopic excision of endometriosisPregnancyActive or chronic relapsing pelvic inflammatory diseaseSuspected gynaecological malignancyCurrently on prescribed Codeine and/or prescribed OpiatesPlanned laparoscopic hysterectomyPoor comprehension of written and spoken English.

Outcome results